Addiction in Women: Sex Differences, Unique Risks, and Treatment Considerations

Introduction

Addiction has historically been studied primarily in men, and treatment programs have been designed primarily for men. Yet women experience addiction differently — they progress more rapidly from initial use to dependence (a phenomenon called "telescoping"), experience different health consequences, face different barriers to treatment, and have different treatment needs. Understanding the sex differences in addiction is essential for providing effective, gender-responsive care.

Key Definitions

Telescoping: The phenomenon in which women progress more rapidly from initial substance use to dependence and experience more severe consequences at lower levels of use than men.

Gender-responsive treatment: Treatment that addresses the specific needs, experiences, and circumstances of women, including trauma history, childcare responsibilities, and relationship dynamics.

Neonatal opioid withdrawal syndrome (NOWS): A condition in newborns exposed to opioids in utero, characterized by irritability, feeding difficulties, and other withdrawal symptoms.

Fetal alcohol spectrum disorders (FASD): A range of conditions caused by prenatal alcohol exposure, including fetal alcohol syndrome (FAS).

Co-occurring trauma: The high rates of trauma — particularly sexual and physical abuse — in women with addiction. Trauma-informed care is essential for women in treatment.

Sex Differences in Addiction Biology

Biological differences between men and women affect addiction risk, progression, and treatment response:

Pharmacokinetics: Women generally have lower body water content and higher body fat percentage than men, affecting drug distribution. Women also have lower levels of alcohol dehydrogenase (the enzyme that metabolizes alcohol in the stomach), meaning that the same amount of alcohol produces higher blood alcohol concentrations in women than in men of the same weight.

Hormonal influences: Sex hormones — estrogen, progesterone, and testosterone — affect the reward circuit and addiction vulnerability. Estrogen enhances dopamine signaling in the reward circuit, potentially increasing the rewarding effects of substances in women. Research has found that women are more vulnerable to the rewarding effects of cocaine and other stimulants during the follicular phase of the menstrual cycle (when estrogen is high).

Stress response: Women show different stress response patterns than men, with greater HPA axis reactivity and greater sensitivity to stress-induced craving. This may contribute to the higher rates of stress-related substance use in women.

Telescoping: Women progress more rapidly from initial substance use to dependence and experience more severe consequences at lower levels of use than men. This telescoping effect has been documented for alcohol, cocaine, opioids, and cannabis. The mechanisms are not fully understood but likely involve the hormonal and pharmacokinetic differences described above.

Unique Risk Factors for Women

Trauma and abuse: Women with addiction have dramatically elevated rates of trauma — particularly sexual and physical abuse — compared to both men with addiction and women without addiction. Research has found that 55-99% of women in addiction treatment have experienced trauma. Trauma is both a risk factor for addiction and a barrier to recovery.

Relationship dynamics: Women are more likely than men to begin using substances in the context of a romantic relationship — often with a partner who uses substances. Relationship dynamics — including intimate partner violence, codependency, and social pressure — play a more prominent role in women's addiction than in men's.

Mental health: Women with addiction have higher rates of co-occurring depression, anxiety, PTSD, and eating disorders than men with addiction. These co-occurring conditions must be addressed in treatment.

Stigma: Women with addiction face greater stigma than men, particularly around parenting. Fear of losing custody of children is a major barrier to treatment-seeking for women.

Pregnancy and Addiction

Addiction during pregnancy presents unique challenges and requires specialized care:

Opioid use disorder in pregnancy: Untreated opioid use disorder during pregnancy is associated with preterm birth, low birth weight, and neonatal opioid withdrawal syndrome (NOWS). Medication-assisted treatment with buprenorphine or methadone is the standard of care for opioid use disorder in pregnancy — it is safer for both mother and baby than untreated addiction or medically supervised withdrawal. Babies born to mothers on MAT may experience NOWS, which is manageable with appropriate medical care.

Alcohol use in pregnancy: There is no safe level of alcohol consumption during pregnancy. Prenatal alcohol exposure can cause fetal alcohol spectrum disorders (FASD), which include a range of physical, cognitive, and behavioral impairments. FAS — the most severe form — is characterized by facial abnormalities, growth restriction, and intellectual disability.

Cannabis use in pregnancy: Cannabis use during pregnancy is associated with preterm birth, low birth weight, and neurodevelopmental effects in children. Despite increasing social acceptance, cannabis is not safe during pregnancy.

Gender-Responsive Treatment

Women respond better to gender-responsive treatment that addresses their specific needs:

Trauma-informed care: Given the high rates of trauma in women with addiction, trauma-informed care is essential. This means recognizing the role of trauma in addiction, creating safe treatment environments, and providing trauma-specific treatment when indicated.

Childcare and family services: Childcare responsibilities are a major barrier to treatment for women. Treatment programs that provide childcare or allow children to accompany mothers have better engagement and outcomes.

Addressing relationship dynamics: Treatment should address the relationship dynamics that contribute to women's substance use, including intimate partner violence, codependency, and social pressure.

Co-occurring mental health treatment: Integrated treatment that addresses both addiction and co-occurring mental health conditions — particularly depression, anxiety, PTSD, and eating disorders — is essential for women.

Frequently Asked Questions

Do women need different addiction treatment than men?
Research suggests that women have better outcomes in gender-specific or gender-responsive treatment programs that address their unique needs — including trauma history, childcare responsibilities, and relationship dynamics. However, mixed-gender programs can also be effective when they are trauma-informed and address women's specific needs.

Is it safe to use MAT during pregnancy?
Yes. Buprenorphine and methadone are the standard of care for opioid use disorder during pregnancy. They are safer for both mother and baby than untreated addiction or medically supervised withdrawal. Babies born to mothers on MAT may experience NOWS, which is manageable with appropriate medical care.

Why do women progress to addiction faster than men?
The telescoping effect in women is likely due to a combination of pharmacokinetic differences (women achieve higher blood concentrations of substances at the same dose), hormonal influences (estrogen enhances reward circuit sensitivity), and psychological factors (higher rates of trauma and stress-related substance use).

Key Takeaways

• Women progress more rapidly from initial substance use to dependence (telescoping) and experience more severe consequences at lower levels of use than men.
• Women with addiction have dramatically elevated rates of trauma, which must be addressed in treatment.
• MAT with buprenorphine or methadone is the standard of care for opioid use disorder in pregnancy.
• Gender-responsive treatment that addresses trauma, childcare, relationship dynamics, and co-occurring mental health conditions produces better outcomes for women.
• Stigma — particularly around parenting — is a major barrier to treatment-seeking for women and must be actively addressed.

Additional Resources

Related articles on Sobriety Navigator: Genetics and Substance Use Disorders, Trauma and Brain Changes, Addiction and Depression, Medication-Assisted Treatment.